IRCT20180723040567N1CompletedPhase 3
Effect of Withania somnifera Root Extract on Anxiety Symptoms in Children with Attention deficite and Hyperactivity Disorder
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Enrollment
- 28
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 7 years to 12 years (—)
- Sex
- All
Inclusion Criteria
- •Diagnosis of ADHD based on DSM-5 criteria
- •aged 7-12 years
- •Complete consent form by parent or guardian
- •Symptoms of simultaneous anxiety
Exclusion Criteria
- •The patient's unwillingness to participating in the research project
- •Systemic disease
- •Interventional psychiatric illness
- •intellectual disability
Investigators
Similar Trials
Completed
Phase 3
effect of Withania somnifera root extract in generalized anxiety disorderIRCT20180615040105N1Mashhad University of Medical Sciences40
Completed
Not Applicable
Evaluation of effect of withania somniferas (Ashwagandha) on stress induced cardiovascular changes in healthy human subjectsCTRI/2013/05/003651Indian Council of Medical Research24
Completed
Phase 2
Evaluating the effect of Withania Somnifera on obsessioObsessive-compulsive disorder.Mixed obsessional thoughts and actsIRCT2015070523079N1Mashhad University of Medical Sciences30
Terminated
Phase 2
Adjunctive Withania Somnifera (Ashwagandha) for Persistent Symptoms in People With SchizophreniaSchizophreniaNCT03437668Chengappa, K.N. Roy, MD47
Not yet recruiting
Unknown
The Effects of Acanthopanax senticosus on Anxiety, Motivation to Learn, Sleep Status, and Fatigue Associated with Learning Status in Studentsmale/female adultsJPRN-UMIN000052295Suzuka University of Medical Science20